Eye numbing gel may weaken infection protection, study warns
NCT ID NCT05934253
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether a numbing gel (chloroprocaine) used before eye procedures might block the germ-killing action of povidone-iodine, compared to standard numbing drops. Researchers took bacterial swabs from 100 adults before and after applying the medications. The goal was to see if the gel's thickness prevents iodine from killing bacteria on the eye surface.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chloroprocaine ophthalmic gel 3%
- What this could lead to
- If it works, this could help doctors choose the best numbing drops for eye procedures without reducing infection prevention.
- What could go wrong
- This is a small, completed study with only 100 participants, so results may not apply to everyone. It only measures bacteria on the eye surface, not actual infection rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA, LOCAL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brandon Eye Associates
Brandon, Florida, 33511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a computer replace the dentist's needle for less painful shots?
- Could kids have upper limb surgery fully awake? new trial tests the idea
- AI predicts dental numbing success in painful tooth condition
- Skin cancer surgery pain showdown: four numbing drugs compared in major trial
- Hip fracture pain study halted early – results uncertain
- New pain block technique tested for heart surgery recovery